Retail for smaller players: Our approach integrates back-office operations, decentralized networks, and microdistribution, empowering underdogs to thrive against industry giants, reshaping the retail landscape. #Buytoken #BUY #Dropshipping #Delivery #ODDS #B2C Read more https://medium.com/buying-com/empowering-small-retailers-with-a-game-changing-tool-powered-by-buying-d5b34974c47a

Triall Insights 🔍 Composite success rates in oncology clinical trials have been trending downward since 2015, falling to 3.5% in 2022. This decline reflects the complex nature of cancer research, which knows one of the lowest success rates among all therapeutic areas. Success rates are however highly variable across oncology products, with rare and haematological cancer products seeing higher success on average compared to non-rare and solid tumour cancers. Source: iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2023 🗣️ Help spread the news: https://x.com/triallofficial/status/1726582443430535290?s=20 #blockchainforhealth #TRL

Triall Insights 🔍 Composite success rates in oncology clinical trials have been trending downward since 2015, falling to 3.5% in 2022. This decline reflects the complex nature of cancer research, which knows one of the lowest success rates among all therapeutic areas. Success rates are however highly variable across oncology products, with rare and haematological cancer products seeing higher success on average compared to non-rare and solid tumour cancers. Source: iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2023 🗣️ Help spread the news: https://x.com/triallofficial/status/1726582443430535290?s=20 #blockchainforhealth #TRL